Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
about
Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutationsPathobiology of pulmonary arterial hypertension and right ventricular failureThe genetics of pulmonary arterial hypertensionRecent progress in understanding pediatric pulmonary hypertensionPulmonary arterial hypertension: an updateA brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisPediatric pulmonary arterial hypertension.Kidney dysfunction in patients with pulmonary arterial hypertensionDevelopment of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular functionHeritable forms of pulmonary arterial hypertension.Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.A novel BMPR2 mutation associated with pulmonary arterial hypertension in an octogenarian.BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type miceVariations in CRHR1 are associated with persistent pulmonary hypertension of the newborn.Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 geneGenetic counselling for pulmonary arterial hypertension: a matter of variable variabilityPulmonary arterial hypertension: insights from genetic studies.Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.The genetics of pulmonary arterial hypertension in the post-BMPR2 era.Associated pulmonary arterial hypertension in connective tissue diseases.A host-guest relationship in bone morphogenetic protein receptor-II defines specificity in ligand-receptor recognition.Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.A Functional Variant rs6435156C > T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese PopulationPulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension.Future perspectives for the treatment of pulmonary arterial hypertension.Genetics and genomics of pulmonary arterial hypertension.Genetics of pulmonary arterial hypertension.Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.Update in pulmonary hypertension 2008.Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.Gene therapy for pulmonary hypertension: prospects and challenges.Pulmonary veno-occlusive disease: advances in clinical management and treatments.HIV infection and pulmonary arterial hypertension.
P2860
Q24303490-E1D4A9AA-48B6-410E-AC69-FB1D26A91F8CQ26821779-4B5D7BB7-B85E-4E0F-8773-AC5DA6A6573BQ27027507-8EB64E1C-68BE-42F5-9579-DFB32F6B16F7Q27691453-2BAEBA07-9111-4138-96BB-D91704AE74DBQ30472109-4DF0F5A0-BCF9-4E08-B236-D127567D61DBQ30544892-5AEBAC02-BEFA-4D5A-AA90-31F1E461A24DQ31038854-CC4955E2-D879-4F1D-950C-4B9C05FF4F20Q33163446-5114A84D-585D-4477-BE37-1BA98ED9932FQ33738621-4E4C8923-B132-425F-B751-4E3AFDDCD141Q33786374-36E45645-1E12-4488-9899-CA6ADF11BD4EQ33806077-36CFA473-BB54-4AC1-83ED-E8D7CE562916Q33915567-96369F69-40A1-4C85-BD62-1B0013BA71D7Q33968765-E3540292-73CE-4DF7-ABA7-0CC8B523A90CQ33970081-1F027A69-6276-4A18-A9D7-B97AF0D4C6A7Q34180789-9E1CFCDB-6C2A-43FC-A697-D8C2AA9E456AQ34199837-628DF732-E3B9-488E-906B-12649C520C0EQ34248154-E56AC7B7-6566-4011-8810-E77BF79132E8Q34576173-E5483084-418A-4965-B5D5-CB55FDC2E91FQ34801954-04896157-BC51-4E41-A219-84F04180D574Q35092474-81C481E6-E105-436E-91D2-A4ABA08C38DBQ35185797-6BC4FA98-3A6B-477E-B8E6-EA3060FF135EQ35573919-C80E6CEB-5183-48CA-B4FB-9FD542B3B92CQ35617799-A3C26DE9-3018-493E-84ED-BA36A2C46BA3Q36348409-74423720-0551-47CC-83C4-9DFEEADED310Q36541797-096EEF69-C67B-4864-B3D1-F4587BF50774Q36754116-B0F6640C-2019-41D6-A1AC-6272C12EE568Q36769101-FB1D1D52-4874-46C2-9BFB-7FDC7C6CB490Q36777766-FAA01DF1-0192-4205-9168-DDC2F46E934DQ36818791-795D547C-6507-43AA-84BC-4A252D0D36A3Q36943648-984542B1-8044-42E5-8A90-261EF3786DDBQ37051037-C8AFC42E-D106-4F13-AD18-CD231D32FC94Q37080526-D892BC4A-C481-4173-89D0-33B5EE3C9674Q37298006-745C2C8D-6E85-48A6-ABA4-55D7A9252BADQ37389602-850DB2C1-B858-4166-91A8-A135ECACD0A3Q37436774-5677DFB3-2348-4440-9DB3-AB5D0CD150AFQ37555347-84130FF4-0A4B-483D-9938-FD9BA7A5EC87Q37698113-A7372F1A-4F6C-48A9-B65B-8E21A0C87C3DQ37827155-26CA827A-FADF-4337-A427-32C28FC57D03Q37867672-CFD6733A-6431-4ECD-9CE7-E09CF35AA91BQ37867676-C58BDAE9-F643-4E76-985D-6DA294D48501
P2860
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@en
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@nl
type
label
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@en
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@nl
prefLabel
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@en
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
@nl
P2093
P2860
P50
P1476
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation
@en
P2093
Azzedine Yaici
Barbara Girerd
Benjamin Sztrymf
Florence Coulet
Florent Soubrier
Gerald Simonneau
P2860
P304
P356
10.1164/RCCM.200712-1807OC
P407
P577
2008-03-20T00:00:00Z